Results 181 to 190 of about 41,093 (226)

Evaluation of the efficacy and safety of HyperArc stereotactic radiotherapy for the treatment of lung cancer brain metastasis. [PDF]

Med Oncol
Zhu Y, Chen Z, Zhu L, Zhang T, Chen J, Liu Y, Qiu Z, Wang Y, Wu C.   +8 more
europepmc   +1 more source

The Application of PD‐1 Inhibitors in Immunotherapy for Glioblastoma

The FASEB Journal, Volume 40, Issue 4, 28 February 2026.
The molecular mechanism of PD‐1. When PD‐1 binds to PD‐L1, the ITIM and ITSM domains within PD‐1 are phosphorylated and subsequently recruit SHP‐2. This then dephosphorylates downstream molecules of the TCR, such as PI3K/AKT and ZAP70, reduces the secretion of IFN‐γ, and inhibits the presentation of antigens to T cells via MHC molecules through the ...
Ming‐zhen Dong, Ming Cui, Lin‐zhuo Qu, Hui‐ying Che, Hong‐jian Guan   +4 more
wiley   +1 more source

Safety and Synergy of Capmatinib Plus Stereotactic Radiotherapy in MET Exon 14-Mutated Non-Small Cell Lung Cancer: A Case Report. [PDF]

Cureus
Bensalah O, Naciri M, Boudraa MA, Aouzah F, Kouhen F.   +4 more
europepmc   +1 more source

Stereotactic radiotherapy for brain metastases of non-small cell lung cancer: A comprehensive review. [PDF]

World J Radiol
Khan A, Zhao HF, Meng H, Wu N, Liu LL.
europepmc   +1 more source

Paradigm shift in patients with multiple brain metastases from whole brain radiotherapy to high precision multimodality treatment including stereotactic radiotherapy. [PDF]

J Neurooncol
Crouzen J, Mast M, Kerkhof M, Vos M, van der Vaart T, Tewarie RN, Nabuurs R, Wiggenraad R, Kiderlen M, van der Voort van Zyp N, Petoukhova A, Broekman M, Zindler J.   +12 more
europepmc   +1 more source

Stereotactic body radiotherapy

, 2005
openaire   +1 more source

Patterns of Recurrence After Postoperative Stereotactic Radiotherapy for Brain Metastases. [PDF]

Cancers (Basel)
Crouzen JA, Petoukhova AL, Hakstege M, van Schaik EEMW, Nandoe Tewarie RDS, Nabuurs RJA, Vos MJ, Kerkhof M, van der Vaart T, Koekkoek JAF, Hagenbeek RE, Yildirim FM, Wiltink LM, van der Voort van Zyp NCMG, Kiderlen M, Broekman MLD, Mast ME, Zindler JD.   +17 more
europepmc   +1 more source

Radiogenomics of Stereotactic Radiotherapy: Genetic Mechanisms Underlying Radiosensitivity, Resistance, and Immune Response. [PDF]

Genes (Basel)
Vučinić D, Bukovica Petrc AM, Antončić I, Kolak Radojčić M, Lekić M, Couñago F.   +5 more
europepmc   +1 more source

Hypofractionated stereotactic radiotherapy versus whole-brain radiotherapy following brain metastasis resection: Results of the ESTRON randomized phase 2 trial. [PDF]

Neuro Oncol
El Shafie RA, Bernhardt D, Welzel T, Schiele A, Schmitt D, Thalmann P, Erdem S, Eichkorn T, Paul A, Lang K, König L, Weykamp F, Adeberg S, Lentz-Hommertgen A, Jäkel C, Bozorgmehr F, Thomas M, Sander A, Kieser M, Debus J, Rieken S.   +20 more
europepmc   +1 more source